NBIX earnings: next report 2026-07-30, real EPS beat/miss history, analyst consensus Buy, P/E 25.74. Updated 2026-07-23.
Neurocrine Biosciences (NBIX) Research Hub
Neurocrine Biosciences (NBIX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 156.22 USD (+0.70%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 25.74, market cap 17.61B. This hub links to the full technical, earnings and options research available for NBIX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 156.22 USD (+0.70%) |
| 52-week range | 150.2 USD – 186.12 USD |
| Trend regime | Range |
| 14-day RSI | 39.9 (Bearish) |
| Trailing P/E | 25.74 |
| Market cap | 17.61B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-30 |
Available research for NBIX
Covered Call on NBIX: how it works, illustrative setup around the real 156.22 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NBIX: how it works, illustrative setup around the real 156.22 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NBIX: how it works, illustrative setup around the real 156.22 USD price, max profit/loss, breakeven and when to use it. Educational.
NBIX technical analysis: range, last 156.22 USD, RSI 39.9, 52w range 150.2 USD–186.12 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is NBIX in?
Neurocrine Biosciences (NBIX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is NBIX in an uptrend or downtrend?
As of 2026-09-11, NBIX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NBIX's trailing P/E ratio?
NBIX's trailing P/E is 25.74, with a market cap of 17.61B. See the earnings research page for full valuation detail.
When does NBIX next report earnings?
NBIX is next scheduled to report earnings on 2026-07-30, with a consensus EPS estimate of 1.64 USD.